Q3 Medical Group is a growth stage commercial company which is leading innovations in biodegradable implants and micro invasive endovascular technology for Interventional Radiology, Gastro Intestinal, and open Surgical procedures. Q3's mission is to transform patient pathways through innovation. Q3 does this by developing, manufacturing and commercializing technology that reduces complications, shortens length of stay and eliminates the need for secondary removal procedures and unnecessary imaging or administration. This fulfills Q3's target of: - Providing better patient outcomes and quality of life - Reducing the Total Cost of Care - Providing Hospital Efficiency Gains - Reducing the Carbon Footprint and Waste Generation Our manufacturing site is currently located in Winsen (Luhe) in Germany with future growth plans to have a secondary site in China. We have challenged ourselves to become a global leader in creating, manufacturing and selling innovative medical technology that aligns with our ultimate vision “CREATING VALUE BY HELPING PEOPLE”.
2013